Over the past decade, the number of hospital beds in South Korea increased by approximately 6%, or more than 25,000 beds. More hospitals beds means that the installed base of infusion pumps, and their overall use, will increase. As a result, the number of disposables used with infusion pumps will increase as well, driving growth in all the IV set segments.
Table of Contents
1. Research Methodology
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems And Perform Secondary Research
Step 3: Preparation For Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast And Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review And Market Release
Step 9: Customer Feedback And Market Monitoring
Step 2: Prepare Data Systems And Perform Secondary Research
Step 3: Preparation For Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast And Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review And Market Release
Step 9: Customer Feedback And Market Monitoring
2. Disease Overview
2.1.1 Congestive Heart Failure
2.1.2 Crohn’S Disease
2.1.3 Hemophilia
2.1.4 Immune Deficiencies
2.1.5 Multiple Sclerosis
2.1.2 Crohn’S Disease
2.1.3 Hemophilia
2.1.4 Immune Deficiencies
2.1.5 Multiple Sclerosis
3. Product Assessment
3.1 Introduction
3.2 Product Portfolios
3.2.1 Infusion Pumps
3.2.1.1 Large Volume Infusion Pump
3.2.1.2 Syringe Infusion Pump
3.2.1.3 Patient-Controlled Analgesia
3.2.1.4 Ambulatory Infusion Pump
3.2.1.4.1 Disposable Ambulatory Infusion Pump
3.2.1.4.2 Electronic Ambulatory Infusion Pump
3.2.2 Intravenous Sets
3.2.2.1 Primary Iv Sets
3.2.2.2 Secondary Iv Sets
3.2.2.3 Iv Extensions Sets
3.2.3 Needleless Connectors
3.2.3.1 Split Septum And Blunt Cannula
3.2.3.2 Mechanical Valves
3.2.3.3 Negative Displacement Mechanical Valves
3.2.3.4 Positive Displacement Mechanical Valves
3.2.3.5 Neutral Displacement Mechanical Valves
3.2.3.6 Anti-Reflux Neutral Displacement Mechanical Valves
3.2.3.7 Antimicrobial Mechanical Valves
3.3 Fda Recalls
3.3.1 Baxter
3.3.2 Carefusion (Becton Dickinson)
3.3.3 Hospira (Icu Medical)
3.3.4 Smiths Medical
3.2 Product Portfolios
3.2.1 Infusion Pumps
3.2.1.1 Large Volume Infusion Pump
3.2.1.2 Syringe Infusion Pump
3.2.1.3 Patient-Controlled Analgesia
3.2.1.4 Ambulatory Infusion Pump
3.2.1.4.1 Disposable Ambulatory Infusion Pump
3.2.1.4.2 Electronic Ambulatory Infusion Pump
3.2.2 Intravenous Sets
3.2.2.1 Primary Iv Sets
3.2.2.2 Secondary Iv Sets
3.2.2.3 Iv Extensions Sets
3.2.3 Needleless Connectors
3.2.3.1 Split Septum And Blunt Cannula
3.2.3.2 Mechanical Valves
3.2.3.3 Negative Displacement Mechanical Valves
3.2.3.4 Positive Displacement Mechanical Valves
3.2.3.5 Neutral Displacement Mechanical Valves
3.2.3.6 Anti-Reflux Neutral Displacement Mechanical Valves
3.2.3.7 Antimicrobial Mechanical Valves
3.3 Fda Recalls
3.3.1 Baxter
3.3.2 Carefusion (Becton Dickinson)
3.3.3 Hospira (Icu Medical)
3.3.4 Smiths Medical
4. South Korean Infusion Therapy Device Market Overview
4.1 Introduction
4.2 Currency Exchange Rate
4.3 Market Overview
4.4 Trend Analysis By Segment
4.5 Drivers And Limiters
4.5.1 Market Drivers
4.5.2 Market Limiters
4.6 Competitive Market Share Analysis
4.7 Mergers And Acquisitions
4.8 Company Profiles
4.8.1 Baxter
4.8.2 B. Braun
4.8.3 Carefusion (Becton Dickinson)
4.8.4 Codan
4.8.5 Halyard
4.8.6 Hospira (Icu Medical)
4.8.7 Smiths Medical
4.8.8 Fresenius Kabi
4.8.9 Vygon
4.9 Swot Analysis
4.9.1 Baxter
4.9.2 B. Braun
4.9.3 Carefusion (Becton Dickinson)
4.9.4 Halyard Health
4.9.5 Hospira (Icu Medical)
4.9.6 Smiths Medical
4.2 Currency Exchange Rate
4.3 Market Overview
4.4 Trend Analysis By Segment
4.5 Drivers And Limiters
4.5.1 Market Drivers
4.5.2 Market Limiters
4.6 Competitive Market Share Analysis
4.7 Mergers And Acquisitions
4.8 Company Profiles
4.8.1 Baxter
4.8.2 B. Braun
4.8.3 Carefusion (Becton Dickinson)
4.8.4 Codan
4.8.5 Halyard
4.8.6 Hospira (Icu Medical)
4.8.7 Smiths Medical
4.8.8 Fresenius Kabi
4.8.9 Vygon
4.9 Swot Analysis
4.9.1 Baxter
4.9.2 B. Braun
4.9.3 Carefusion (Becton Dickinson)
4.9.4 Halyard Health
4.9.5 Hospira (Icu Medical)
4.9.6 Smiths Medical
5. Infusion Pump Market
5.1 Introduction
5.1.1 Statistics
5.2 Market Overview
5.3 Market Analysis And Forecast
5.3.1 Large Volume Infusion Pump Market
5.3.2 Total Syringe Infusion Pump Market
5.3.2.1 Premium Syringe Pump Market
5.3.2.2 Value Brand Syringe Pump Market
5.3.3 Patient-Controlled Analgesia Infusion Pump Market
5.3.4 Electronic Ambulatory Infusion Pump Market
5.3.5 Disposable Ambulatory Infusion Pump Market
5.3.5.1 Post-Operative Disposable Ambulatory Pump Market
5.3.5.2 Alternate Care Disposable Ambulatory Pump Market
5.4 Drivers And Limiters
5.4.1 Market Drivers
5.4.2 Market Limiters
5.5 Competitive Market Share Analysis
5.1.1 Statistics
5.2 Market Overview
5.3 Market Analysis And Forecast
5.3.1 Large Volume Infusion Pump Market
5.3.2 Total Syringe Infusion Pump Market
5.3.2.1 Premium Syringe Pump Market
5.3.2.2 Value Brand Syringe Pump Market
5.3.3 Patient-Controlled Analgesia Infusion Pump Market
5.3.4 Electronic Ambulatory Infusion Pump Market
5.3.5 Disposable Ambulatory Infusion Pump Market
5.3.5.1 Post-Operative Disposable Ambulatory Pump Market
5.3.5.2 Alternate Care Disposable Ambulatory Pump Market
5.4 Drivers And Limiters
5.4.1 Market Drivers
5.4.2 Market Limiters
5.5 Competitive Market Share Analysis
6. Intravenous Set Market
6.1 Introduction
6.1.1 Dedicated Primary Iv Sets
6.1.2 Secondary Iv Sets
6.1.3 Iv Extensions Sets
6.2 Market Overview
6.3 Market Analysis And Forecast
6.3.1 Dedicated Primary Iv Set Market
6.3.2 Secondary Iv Set Market
6.3.3 Iv Extension Set Market
6.3.4 Gravity Set Market
6.4 Drivers And Limiters
6.4.1 Market Drivers
6.4.2 Market Limiters
6.5 Competitive Market Share Analysis
6.1.1 Dedicated Primary Iv Sets
6.1.2 Secondary Iv Sets
6.1.3 Iv Extensions Sets
6.2 Market Overview
6.3 Market Analysis And Forecast
6.3.1 Dedicated Primary Iv Set Market
6.3.2 Secondary Iv Set Market
6.3.3 Iv Extension Set Market
6.3.4 Gravity Set Market
6.4 Drivers And Limiters
6.4.1 Market Drivers
6.4.2 Market Limiters
6.5 Competitive Market Share Analysis
7. Needleless Connector Market
7.1 Introduction
7.1.1 Split Septum And Blunt Cannula
7.1.2 Mechanical Valves
7.2 Market Overview
7.3 Market Analysis And Forecast
7.3.1 Total Needleless Connector Market
7.3.2 Needleless Connector Market By Valve Type
7.3.2.1 Split Septum & Blunt Cannula Nlc Market
7.3.2.2 Mechanical Valve Nlc Market
7.4 Drivers And Limiters
7.4.1 Market Drivers
7.4.2 Market Limiters
7.5 Competitive Market Share Analysis
7.1.1 Split Septum And Blunt Cannula
7.1.2 Mechanical Valves
7.2 Market Overview
7.3 Market Analysis And Forecast
7.3.1 Total Needleless Connector Market
7.3.2 Needleless Connector Market By Valve Type
7.3.2.1 Split Septum & Blunt Cannula Nlc Market
7.3.2.2 Mechanical Valve Nlc Market
7.4 Drivers And Limiters
7.4.1 Market Drivers
7.4.2 Market Limiters
7.5 Competitive Market Share Analysis
8. Stopcock Market
8.1 Introduction
8.2 Market Analysis And Forecast
8.3 Drivers And Limiters
8.3.1 Market Drivers
8.3.2 Market Limiters
8.4 Competitive Market Share Analysis
8.2 Market Analysis And Forecast
8.3 Drivers And Limiters
8.3.1 Market Drivers
8.3.2 Market Limiters
8.4 Competitive Market Share Analysis
9. Blood Transfusion Set Market
9.1 Introduction
9.2 Market Analysis And Forecast
9.3 Drivers And Limiters
9.3.1 Market Drivers
9.3.2 Market Limiters
9.4 Competitive Market Share Analysis
9.2 Market Analysis And Forecast
9.3 Drivers And Limiters
9.3.1 Market Drivers
9.3.2 Market Limiters
9.4 Competitive Market Share Analysis
11. Appendix: Company Press Releases
11.1 Introduction
11.2 Press Releases
11.2.1 Baxter International
11.2.1.1 Baxter And The Institute For Safe Medication Practices (Ismp) Address Global Medication Error Prevention
11.2.1.2 New Data Indicates Use Of Baxter's Floseal In Cardiac And Spinal Surgeries May Be Associated With Lower Hospital Costs
11.2.1.3 Baxter And Scinopharm Announce Exclusive Strategic Partnership For Generic Oncology Injectables
11.2.1.4 Baxter Debuts Enteral Nutrition Enfit™ Syringe And Accesory Line During Clinical Nutrition Week 2017
11.2.1.5 Baxter Appoints Dr. Stephen Oesterle To Its Board
11.2.1.6 Baxter Reports 2016 Fourth-Quarter And Full-Year Results
11.2.1.7 Baxter To Expand Portfolio Of Essential Generic Injectable Medicines With Acquisition Of Claris Injectables Limited
11.2.1.8 Baxter Introduces New Safety Management System And Software Updates For Sigma Spectrum Infusion System At Ashp Meeting
11.2.1.9 Baxter's Sigma Spectrum Infusion System Awarded "2016 Best In Klas" Among All Large-Volume Infusion Pumps
11.2.1.10 Baxter Initiates Clinical Trial For Citrate Anticoagulant For Use During Continuous Renal Replacement Therapy
11.2.1.11 Baxter Reports Third Quarter 2016 Results And Increases Financial Outlook For Full-Year 2016
11.2.1.12 Baxter Launches Hdx Therapy Enabled By Theranova To Provide High Performance Hemodialysis Treatments
11.2.1.13 Baxter Initiates Voluntary Recall Of All Unexpired Lots Of 50Mm 0.2 Micron Filters
11.2.1.14 Baxter's Sigma Spectrum Infusion System Rates Highest In Drug Library Compliance And Ease-Of-Use According To Klas Report
11.2.1.15 Baxter Launches Numeta G13E In Europe: Only Ready-To-Use Iv Nutrition For Vulnerable Preterm Newborns At Risk For Malnutrition
11.2.1.16 Baxter's Doseedge Pharmacy System Identifies Potential Medication Errors For Clinicians Prior To Patient Administration
11.2.1.17 Baxter Reports Second Quarter 2016 Results And Raises Financial Outlook For Full-Year 2016
11.2.1.18 Data Show Sigma Spectrum Infusion System Users Achieved 97 Percent Drug Library Compliance Rate Within The First Month Of Implementation
11.2.1.19 Baxter Announces Final Results Of Baxalta Exchange Offer
11.2.1.20 Baxter Announces Preliminary Results Of Baxalta Exchange Offer
11.2.1.21 Baxter Announces Final Exchange Ratio Of 1.1591 For Baxalta Exchange Offer
11.2.1.22 Baxter Highlights Business Strategies And Innovation At 2016 Investor Conference
11.2.1.23 Baxter Announces Appointment Of Interim President For Its Renal Business
11.2.1.24 Baxter Reports First Quarter 2016 Results And Provides Updated Financial Outlook For Full-Year 2016
11.2.1.25 Baxter Receives Marketing Authorization In The United Kingdom And Denmark For Numeta G13E Ready-To-Use Iv Nutrition For Preterm Newborns
11.2.1.26 Baxter Announces U.S. Launch Of Premix Drug Vancomycin Injection In Sodium Chloride
11.2.1.27 Baxter Announces Fourth Quarter Results And Provides 2016 Financial Outlook
11.2.1.28 Baxter Initiates Voluntary Nationwide Recall Of Select Lots Of Iv Solutions Due To The Potential For Leaking Containers And Particulate Matter
11.2.2 B. Braun
11.2.2.1 B. Braun Launches Easypump™ Home Infusion Therapy App For Healthcare Professionals And Patients
11.2.2.2 B. Braun And Philips Join Forces To Innovate In Ultrasound-Guided Regional Anesthesia And Vascular Access
11.2.2.3 B. Braun Continues Its Sales And Earnings Growth
11.2.2.4 Change In The B. Braun Management Board
11.2.2.5 B. Braun Medical's Outlook™ Pump Completes Systems Integration With Iatric Systems Accelero Connect™
11.2.2.6 B. Braun To Present New Line Of Echogenic Peripheral Nerve Block Needles At American Society Of Anesthesiologists Meeting
11.2.2.7 B. Braun To Launch Neuraxial Products With Nrfit Connectors At American Society Of Anesthesiologists Meeting
11.2.2.8 B. Braun Platinum Sponsor At Advamed 2016 Medtech Conference
11.2.2.9 B. Braun Medical Acquires Dismed’S Hand Sanitizer And Intravenous Fluid Businesses In South Africa
11.2.2.10 B. Braun's Growth Trend Continues
11.2.3 Carefusion (Becton Dickinson)
11.2.3.1 Becton Dickinson Completes Acquisition Of Carefusion
11.2.4 Halyard Health
11.2.4.1 Halyard Health, Inc. Announces Fourth Quarter And Full-Year 2016 Results, Provides 2017 Outlook
11.2.4.2 Halyard Health, Inc. Announces Third Quarter 2016 Results, Raises Its Full-Year 2016 Outlook
11.2.4.3 Halyard Health, Inc. Announces Second Quarter 2016 Results, Raises Its Full-Year 2016 Outlook
11.2.4.4 Halyard Health, Inc. Announces First Quarter 2016 Results Completes Acquisition Of Corpak Medsystems
11.2.4.5 Halyard Health Announces Agreement To Acquire Corpak Medsystems
11.2.4.6 Halyard Health, Inc. Year-End 2015 Results And 2016 Outlook
11.2.5 Hospira (Icu Medical)
11.2.5.1 Hospira And Iatric Systems Partner To Deliver Smart Pump-Emr Interoperability To Hospitals
11.2.5.2 Lancaster General Hospital Becomes World's First Hospital To Integrate Emr With Pca Infusion Pump To Drive Safety And Transparency In Patient Pain Management
11.2.5.3 Omnicell's Performance Center Integrates With Hospira's Infusion Pump Software
11.2.5.4 Hospira Launches Lifecare Pca™ 7.0 Infusion System, First Pca Pump That Integrates With The Electronic Medical Record
11.2.5.5 Hospira Announces First Installation Of Plum 360™ Infusion System With Hospira Mednet™
11.2.5.6 Hospira And Cerner Expand Agreement To Advance Integration Of I.V.-Emr Technology
11.2.5.7 Hospira Receives Fda Clearance For Plum 360™ Infusion System
11.2.6 Smiths Medical
11.2.6.1 Acapella Choice Vibratory Pep Therapy System Shown To Reduce Hospital Length Of Stay
11.2.6.2 Smiths Medical Launches Pharmguard™ Interoperatbility Software For Smart Pump Programming
11.2.6.3 Smiths Medica’S Pharmguard Interoperability Software Now Fully Tested With Emr For Smart Pump Programming
11.2.6.4 Smiths Medical Launches New Wireless Ambulatory Infusion System In Four Markets
11.2.6.5 Smiths Medical Receives Innovative Technology Designation From Vizient, Inc
11.2.7 Fresenius Kabi
11.2.7.1 Fresenius Kabi Builds New Warehouse At Blonie Production Site
11.2.7.2 Fresenius Reports 13Th Consectutive Record Year And Targets Continued Strong Growth
11.2.7.3 Fresenius Kabi Acquires Ready-To-Administer Drugs And U.S. Pharmaceutical Plant From Becton Dickinson
11.2.8 Vygon
11.2.8.1 Vygon’S Two-Way Valve Code 850.00 To Be Discontinued
11.2.8.2 Vygon To Market Secuderm™, A Waterproof Secondary Dressing That Protects Catheters From Infection
11.2 Press Releases
11.2.1 Baxter International
11.2.1.1 Baxter And The Institute For Safe Medication Practices (Ismp) Address Global Medication Error Prevention
11.2.1.2 New Data Indicates Use Of Baxter's Floseal In Cardiac And Spinal Surgeries May Be Associated With Lower Hospital Costs
11.2.1.3 Baxter And Scinopharm Announce Exclusive Strategic Partnership For Generic Oncology Injectables
11.2.1.4 Baxter Debuts Enteral Nutrition Enfit™ Syringe And Accesory Line During Clinical Nutrition Week 2017
11.2.1.5 Baxter Appoints Dr. Stephen Oesterle To Its Board
11.2.1.6 Baxter Reports 2016 Fourth-Quarter And Full-Year Results
11.2.1.7 Baxter To Expand Portfolio Of Essential Generic Injectable Medicines With Acquisition Of Claris Injectables Limited
11.2.1.8 Baxter Introduces New Safety Management System And Software Updates For Sigma Spectrum Infusion System At Ashp Meeting
11.2.1.9 Baxter's Sigma Spectrum Infusion System Awarded "2016 Best In Klas" Among All Large-Volume Infusion Pumps
11.2.1.10 Baxter Initiates Clinical Trial For Citrate Anticoagulant For Use During Continuous Renal Replacement Therapy
11.2.1.11 Baxter Reports Third Quarter 2016 Results And Increases Financial Outlook For Full-Year 2016
11.2.1.12 Baxter Launches Hdx Therapy Enabled By Theranova To Provide High Performance Hemodialysis Treatments
11.2.1.13 Baxter Initiates Voluntary Recall Of All Unexpired Lots Of 50Mm 0.2 Micron Filters
11.2.1.14 Baxter's Sigma Spectrum Infusion System Rates Highest In Drug Library Compliance And Ease-Of-Use According To Klas Report
11.2.1.15 Baxter Launches Numeta G13E In Europe: Only Ready-To-Use Iv Nutrition For Vulnerable Preterm Newborns At Risk For Malnutrition
11.2.1.16 Baxter's Doseedge Pharmacy System Identifies Potential Medication Errors For Clinicians Prior To Patient Administration
11.2.1.17 Baxter Reports Second Quarter 2016 Results And Raises Financial Outlook For Full-Year 2016
11.2.1.18 Data Show Sigma Spectrum Infusion System Users Achieved 97 Percent Drug Library Compliance Rate Within The First Month Of Implementation
11.2.1.19 Baxter Announces Final Results Of Baxalta Exchange Offer
11.2.1.20 Baxter Announces Preliminary Results Of Baxalta Exchange Offer
11.2.1.21 Baxter Announces Final Exchange Ratio Of 1.1591 For Baxalta Exchange Offer
11.2.1.22 Baxter Highlights Business Strategies And Innovation At 2016 Investor Conference
11.2.1.23 Baxter Announces Appointment Of Interim President For Its Renal Business
11.2.1.24 Baxter Reports First Quarter 2016 Results And Provides Updated Financial Outlook For Full-Year 2016
11.2.1.25 Baxter Receives Marketing Authorization In The United Kingdom And Denmark For Numeta G13E Ready-To-Use Iv Nutrition For Preterm Newborns
11.2.1.26 Baxter Announces U.S. Launch Of Premix Drug Vancomycin Injection In Sodium Chloride
11.2.1.27 Baxter Announces Fourth Quarter Results And Provides 2016 Financial Outlook
11.2.1.28 Baxter Initiates Voluntary Nationwide Recall Of Select Lots Of Iv Solutions Due To The Potential For Leaking Containers And Particulate Matter
11.2.2 B. Braun
11.2.2.1 B. Braun Launches Easypump™ Home Infusion Therapy App For Healthcare Professionals And Patients
11.2.2.2 B. Braun And Philips Join Forces To Innovate In Ultrasound-Guided Regional Anesthesia And Vascular Access
11.2.2.3 B. Braun Continues Its Sales And Earnings Growth
11.2.2.4 Change In The B. Braun Management Board
11.2.2.5 B. Braun Medical's Outlook™ Pump Completes Systems Integration With Iatric Systems Accelero Connect™
11.2.2.6 B. Braun To Present New Line Of Echogenic Peripheral Nerve Block Needles At American Society Of Anesthesiologists Meeting
11.2.2.7 B. Braun To Launch Neuraxial Products With Nrfit Connectors At American Society Of Anesthesiologists Meeting
11.2.2.8 B. Braun Platinum Sponsor At Advamed 2016 Medtech Conference
11.2.2.9 B. Braun Medical Acquires Dismed’S Hand Sanitizer And Intravenous Fluid Businesses In South Africa
11.2.2.10 B. Braun's Growth Trend Continues
11.2.3 Carefusion (Becton Dickinson)
11.2.3.1 Becton Dickinson Completes Acquisition Of Carefusion
11.2.4 Halyard Health
11.2.4.1 Halyard Health, Inc. Announces Fourth Quarter And Full-Year 2016 Results, Provides 2017 Outlook
11.2.4.2 Halyard Health, Inc. Announces Third Quarter 2016 Results, Raises Its Full-Year 2016 Outlook
11.2.4.3 Halyard Health, Inc. Announces Second Quarter 2016 Results, Raises Its Full-Year 2016 Outlook
11.2.4.4 Halyard Health, Inc. Announces First Quarter 2016 Results Completes Acquisition Of Corpak Medsystems
11.2.4.5 Halyard Health Announces Agreement To Acquire Corpak Medsystems
11.2.4.6 Halyard Health, Inc. Year-End 2015 Results And 2016 Outlook
11.2.5 Hospira (Icu Medical)
11.2.5.1 Hospira And Iatric Systems Partner To Deliver Smart Pump-Emr Interoperability To Hospitals
11.2.5.2 Lancaster General Hospital Becomes World's First Hospital To Integrate Emr With Pca Infusion Pump To Drive Safety And Transparency In Patient Pain Management
11.2.5.3 Omnicell's Performance Center Integrates With Hospira's Infusion Pump Software
11.2.5.4 Hospira Launches Lifecare Pca™ 7.0 Infusion System, First Pca Pump That Integrates With The Electronic Medical Record
11.2.5.5 Hospira Announces First Installation Of Plum 360™ Infusion System With Hospira Mednet™
11.2.5.6 Hospira And Cerner Expand Agreement To Advance Integration Of I.V.-Emr Technology
11.2.5.7 Hospira Receives Fda Clearance For Plum 360™ Infusion System
11.2.6 Smiths Medical
11.2.6.1 Acapella Choice Vibratory Pep Therapy System Shown To Reduce Hospital Length Of Stay
11.2.6.2 Smiths Medical Launches Pharmguard™ Interoperatbility Software For Smart Pump Programming
11.2.6.3 Smiths Medica’S Pharmguard Interoperability Software Now Fully Tested With Emr For Smart Pump Programming
11.2.6.4 Smiths Medical Launches New Wireless Ambulatory Infusion System In Four Markets
11.2.6.5 Smiths Medical Receives Innovative Technology Designation From Vizient, Inc
11.2.7 Fresenius Kabi
11.2.7.1 Fresenius Kabi Builds New Warehouse At Blonie Production Site
11.2.7.2 Fresenius Reports 13Th Consectutive Record Year And Targets Continued Strong Growth
11.2.7.3 Fresenius Kabi Acquires Ready-To-Administer Drugs And U.S. Pharmaceutical Plant From Becton Dickinson
11.2.8 Vygon
11.2.8.1 Vygon’S Two-Way Valve Code 850.00 To Be Discontinued
11.2.8.2 Vygon To Market Secuderm™, A Waterproof Secondary Dressing That Protects Catheters From Infection
List of Charts
Chart 1 1: Infusion Therapy Device Market By Segment, South Korea, 2014 – 2024
Chart 1 2: Infusion Therapy Device Market By Segment, South Korea, 2017 & 2024
Chart 4 1: Infusion Therapy Device Market By Segment, South Korea, 2014 – 2024
Chart 4 2: Infusion Therapy Device Market Breakdown, South Korea, 2017
Chart 4 3: Infusion Therapy Device Market Breakdown, South Korea, 2024
Chart 4 4: Infusion Therapy Device Market Growth By Segment, South Korea, 2015 – 2024
Chart 4 5: Leading Competitors, Infusion Therapy Device Market, South Korea, 2017
Chart 5 1: Infusion Pump Market By Segment, South Korea, 2014 – 2024
Chart 5 2: Infusion Pump Market Breakdown, South Korea, 2017
Chart 5 3: Infusion Pump Market Breakdown, South Korea, 2024
Chart 5 4: Large Volume Infusion Pump Market, South Korea, 2014 – 2024
Chart 5 5: Syringe Infusion Pump Market By Segment, South Korea, 2014 – 2024
Chart 5 6: Total Syringe Infusion Pump Market, South Korea, 2014 – 2024
Chart 5 7: Premium Syringe Pump Market, South Korea, 2014 – 2024
Chart 5 8: Value Brand Syringe Pump Market, South Korea, 2014 – 2024
Chart 5 9: Patient-Controlled Analgesia Infusion Pump Market, South Korea, 2014 – 2024
Chart 5 10: Electronic Ambulatory Infusion Pump Market, South Korea, 2014 – 2024
Chart 5 11: Disposable Ambulatory Infusion Pump Market By Segment, South Korea, 2014 – 2024
Chart 5 12: Total Disposable Ambulatory Infusion Pump Market, South Korea, 2014 – 2024
Chart 5 13: Post-Operative Disposable Ambulatory Pump Market, South Korea, 2014 – 2024
Chart 5 14: Alternate Care Disposable Ambulatory Pump Market, South Korea, 2014 – 2024
Chart 5 15: Leading Competitors, Infusion Pump Market, South Korea, 2017
Chart 6 1: Intravenous Set Market By Segment, South Korea, 2014 – 2024
Chart 6 2: Intravenous Set Market Breakdown, South Korea, 2017
Chart 6 3: Intravenous Set Market Breakdown, South Korea, 2024
Chart 6 4: Dedicated Primary Iv Set Market, South Korea, 2014 – 2024
Chart 6 5: Secondary Iv Set Market, South Korea, 2014 – 2024
Chart 6 6: Iv Extension Set Market, South Korea, 2014 – 2024
Chart 6 7: Gravity Set Market, South Korea, 2014 – 2024
Chart 6 8: Leading Competitors, Intravenous Set Market, South Korea, 2017
Chart 7 1: Needleless Connector Market By Valve Type, South Korea, 2014 – 2024
Chart 7 2: Needleless Connector Market Breakdown By Valve Type, South Korea, 2017
Chart 7 3: Needleless Connector Market Breakdown By Valve Type, South Korea, 2024
Chart 7 4: Total Needleless Connector Market, South Korea, 2014 – 2024
Chart 7 5: Split Septum & Blunt Cannula Nlc Market, South Korea, 2014 – 2024
Chart 7 6: Mechanical Valve Nlc Market, South Korea, 2014 – 2024
Chart 7 7: Leading Competitors, Needleless Connector Market, South Korea, 2017
Chart 8 1: Stopcock Market, South Korea, 2014 – 2024
Chart 9 1: Blood Transfusion Set Market, South Korea, 2014 – 2024
Chart 1 2: Infusion Therapy Device Market By Segment, South Korea, 2017 & 2024
Chart 4 1: Infusion Therapy Device Market By Segment, South Korea, 2014 – 2024
Chart 4 2: Infusion Therapy Device Market Breakdown, South Korea, 2017
Chart 4 3: Infusion Therapy Device Market Breakdown, South Korea, 2024
Chart 4 4: Infusion Therapy Device Market Growth By Segment, South Korea, 2015 – 2024
Chart 4 5: Leading Competitors, Infusion Therapy Device Market, South Korea, 2017
Chart 5 1: Infusion Pump Market By Segment, South Korea, 2014 – 2024
Chart 5 2: Infusion Pump Market Breakdown, South Korea, 2017
Chart 5 3: Infusion Pump Market Breakdown, South Korea, 2024
Chart 5 4: Large Volume Infusion Pump Market, South Korea, 2014 – 2024
Chart 5 5: Syringe Infusion Pump Market By Segment, South Korea, 2014 – 2024
Chart 5 6: Total Syringe Infusion Pump Market, South Korea, 2014 – 2024
Chart 5 7: Premium Syringe Pump Market, South Korea, 2014 – 2024
Chart 5 8: Value Brand Syringe Pump Market, South Korea, 2014 – 2024
Chart 5 9: Patient-Controlled Analgesia Infusion Pump Market, South Korea, 2014 – 2024
Chart 5 10: Electronic Ambulatory Infusion Pump Market, South Korea, 2014 – 2024
Chart 5 11: Disposable Ambulatory Infusion Pump Market By Segment, South Korea, 2014 – 2024
Chart 5 12: Total Disposable Ambulatory Infusion Pump Market, South Korea, 2014 – 2024
Chart 5 13: Post-Operative Disposable Ambulatory Pump Market, South Korea, 2014 – 2024
Chart 5 14: Alternate Care Disposable Ambulatory Pump Market, South Korea, 2014 – 2024
Chart 5 15: Leading Competitors, Infusion Pump Market, South Korea, 2017
Chart 6 1: Intravenous Set Market By Segment, South Korea, 2014 – 2024
Chart 6 2: Intravenous Set Market Breakdown, South Korea, 2017
Chart 6 3: Intravenous Set Market Breakdown, South Korea, 2024
Chart 6 4: Dedicated Primary Iv Set Market, South Korea, 2014 – 2024
Chart 6 5: Secondary Iv Set Market, South Korea, 2014 – 2024
Chart 6 6: Iv Extension Set Market, South Korea, 2014 – 2024
Chart 6 7: Gravity Set Market, South Korea, 2014 – 2024
Chart 6 8: Leading Competitors, Intravenous Set Market, South Korea, 2017
Chart 7 1: Needleless Connector Market By Valve Type, South Korea, 2014 – 2024
Chart 7 2: Needleless Connector Market Breakdown By Valve Type, South Korea, 2017
Chart 7 3: Needleless Connector Market Breakdown By Valve Type, South Korea, 2024
Chart 7 4: Total Needleless Connector Market, South Korea, 2014 – 2024
Chart 7 5: Split Septum & Blunt Cannula Nlc Market, South Korea, 2014 – 2024
Chart 7 6: Mechanical Valve Nlc Market, South Korea, 2014 – 2024
Chart 7 7: Leading Competitors, Needleless Connector Market, South Korea, 2017
Chart 8 1: Stopcock Market, South Korea, 2014 – 2024
Chart 9 1: Blood Transfusion Set Market, South Korea, 2014 – 2024
List of Figures
Figure 1 1: Infusion Therapy Device Market Share Ranking By Segment, South Korea, 2017
Figure 1 2: Companies Researched In This Report, South Korea, 2017
Figure 1 3: Factors Impacting The Infusion Therapy Device Market By Segment, South Korea (1 Of 2)
Figure 1 4: Factors Impacting The Infusion Therapy Device Market By Segment, South Korea (2 Of 2)
Figure 1 5: Recent Events In The Infusion Therapy Device Market, South Korea, 2014 – 2017
Figure 1 6: Infusion Therapy Device Markets Covered, South Korea, 2017
Figure 1 7: Key Report Updates
Figure 1 8: Version History
Figure 3 1: Large Volume Infusion Pumps By Company
Figure 3 2: Syringe Infusion Pumps By Company
Figure 3 3: Patient-Controlled Analgesia Devices By Company
Figure 3 4: Disposable Ambulatory Infusion Pumps By Company
Figure 3 5: Electronic Ambulatory Infusion Pumps By Company
Figure 3 6: Intravenous Sets By Company
Figure 3 7: Needleless Connectors By Company
Figure 3 8: Class 2 Device Recall Baxter
Figure 3 9: Class 2 Device Recall Carefusion
Figure 3 10: Class 2 Device Recall Carefusion
Figure 3 11: Class 2 Device Recall Carefusion
Figure 3 12: Class 2 Device Recall Hospira
Figure 3 13: Class 2 Device Recall Hospira
Figure 3 14: Class 2 Device Recall Hospira
Figure 3 15: Class 2 Device Recall Hospira
Figure 3 16: Class 2 Device Recall Hospira
Figure 3 17: Class 2 Device Recall Hospira
Figure 3 18: Class 2 Device Recall Hospira
Figure 3 19: Class 2 Device Recall Hospira
Figure 3 20: Class 2 Device Recall Hospira
Figure 3 21: Class 2 Device Recall Hospira
Figure 3 22: Class 2 Device Recall Hospira
Figure 3 23: Class 2 Device Recall Smiths Medical
Figure 4 1: Currency Exchange Rate, 2017
Figure 4 2: Infusion Therapy Device Market By Segment, South Korea, 2014 – 2024 (Us$M)
Figure 4 3: Infusion Therapy Device Market By Segment, South Korea, 2014 – 2024 (Kr?M)
Figure 4 4: Infusion Therapy Device Market Growth By Segment, South Korea, 2014 – 2024
Figure 4 5: Drivers And Limiters, Infusion Therapy Device Market, South Korea, 2017
Figure 4 6: Leading Competitors, Infusion Therapy Device Market, South Korea, 2017
Figure 4 7: Swot Analysis, Baxter
Figure 4 8: Swot Analysis, B. Braun
Figure 4 9: Swot Analysis, Carefusion (Becton Dickinson)
Figure 4 10: Swot Analysis, Halyard
Figure 4 11: Swot Analysis, Hospira (Icu Medical)
Figure 4 12: Swot Analysis, Smiths Medical
Figure 5 1: Hospital Statistics, South Korea, 2014 – 2024
Figure 5 2: Infusion Pump Market By Segment, South Korea, 2014 – 2024 (Us$M)
Figure 5 3: Infusion Pump Market By Segment, South Korea, 2014 – 2024 (Kr?M)
Figure 5 4: Large Volume Infusion Pump Market, South Korea, 2014 – 2024
Figure 5 5: Syringe Infusion Pump Market By Segment, South Korea, 2014 – 2024 (Us$M)
Figure 5 6: Syringe Infusion Pump Market By Segment, South Korea, 2014 – 2024 (Kr?M)
Figure 5 7: Total Syringe Infusion Pump Market, South Korea, 2014 – 2024
Figure 5 8: Premium Syringe Pump Market, South Korea, 2014 – 2024
Figure 5 9: Value Brand Syringe Pump Market, South Korea, 2014 – 2024
Figure 5 10: Patient-Controlled Analgesia Infusion Pump Market, South Korea, 2014 – 2024
Figure 5 11: Electronic Ambulatory Infusion Pump Market, South Korea, 2014 – 2024
Figure 5 12: Disposable Ambulatory Infusion Pump Market By Segment, South Korea, 2014 – 2024 (Us$M)
Figure 5 13: Disposable Ambulatory Infusion Pump Market By Segment, South Korea, 2014 – 2024 (Kr?M)
Figure 5 14: Total Disposable Ambulatory Infusion Pump Market, South Korea, 2014 – 2024
Figure 5 15: Post-Operative Disposable Ambulatory Pump Market, South Korea, 2014 – 2024
Figure 5 16: Alternate Care Disposable Ambulatory Pump Market, South Korea, 2014 – 2024
Figure 5 17: Drivers And Limiters, Infusion Pump Market, South Korea, 2017
Figure 5 18: Leading Competitors, Infusion Pump Market, South Korea, 2017
Figure 6 1: Intravenous Set Market By Segment, South Korea, 2014 – 2024 (Us$M)
Figure 6 2: Intravenous Set Market By Segment, South Korea, 2014 – 2024 (Kr?M)
Figure 6 3: Dedicated Primary Iv Set Market, South Korea, 2014 – 2024
Figure 6 4: Secondary Iv Set Market, South Korea, 2014 – 2024
Figure 6 5: Iv Extension Set Market, South Korea, 2014 – 2024
Figure 6 6: Gravity Set Market, South Korea, 2014 – 2024
Figure 6 7: Drivers And Limiters, Intravenous Set Market, South Korea, 2017
Figure 6 8: Leading Competitors, Intravenous Set Market, South Korea, 2017
Figure 7 1: Needleless Connector Market Overview By Valve Type, South Korea, 2014 – 2024 (Us$M)
Figure 7 2: Needleless Connector Market Overview By Valve Type, South Korea, 2014 – 2024 (Kr?M)
Figure 7 3: Total Needleless Connector Market, South Korea, 2014 – 2024
Figure 7 4: Split Septum & Blunt Cannula Nlc Market, South Korea, 2014 – 2024
Figure 7 5: Mechanical Valve Nlc Market, South Korea, 2014 – 2024
Figure 7 6: Drivers And Limiters, Needleless Connector Market, South Korea, 2017
Figure 7 7: Leading Competitors, Needleless Connector Market, South Korea, 2017
Figure 8 1: Stopcock Market, South Korea, 2014 – 2024
Figure 8 2: Drivers And Limiters, Stopcock Market, South Korea, 2017
Figure 8 3: Market Competitors, Stopcock Market, South Korea, 2017
Figure 9 1: Blood Transfusion Set Market, South Korea, 2014 – 2024
Figure 9 2: Drivers And Limiters, Blood Transfusion Set Market, South Korea, 2017
Figure 9 3: Market Competitors, Blood Transfusion Set Market, South Korea, 2017
Figure 11 1: Press Release Summary
Figure 1 2: Companies Researched In This Report, South Korea, 2017
Figure 1 3: Factors Impacting The Infusion Therapy Device Market By Segment, South Korea (1 Of 2)
Figure 1 4: Factors Impacting The Infusion Therapy Device Market By Segment, South Korea (2 Of 2)
Figure 1 5: Recent Events In The Infusion Therapy Device Market, South Korea, 2014 – 2017
Figure 1 6: Infusion Therapy Device Markets Covered, South Korea, 2017
Figure 1 7: Key Report Updates
Figure 1 8: Version History
Figure 3 1: Large Volume Infusion Pumps By Company
Figure 3 2: Syringe Infusion Pumps By Company
Figure 3 3: Patient-Controlled Analgesia Devices By Company
Figure 3 4: Disposable Ambulatory Infusion Pumps By Company
Figure 3 5: Electronic Ambulatory Infusion Pumps By Company
Figure 3 6: Intravenous Sets By Company
Figure 3 7: Needleless Connectors By Company
Figure 3 8: Class 2 Device Recall Baxter
Figure 3 9: Class 2 Device Recall Carefusion
Figure 3 10: Class 2 Device Recall Carefusion
Figure 3 11: Class 2 Device Recall Carefusion
Figure 3 12: Class 2 Device Recall Hospira
Figure 3 13: Class 2 Device Recall Hospira
Figure 3 14: Class 2 Device Recall Hospira
Figure 3 15: Class 2 Device Recall Hospira
Figure 3 16: Class 2 Device Recall Hospira
Figure 3 17: Class 2 Device Recall Hospira
Figure 3 18: Class 2 Device Recall Hospira
Figure 3 19: Class 2 Device Recall Hospira
Figure 3 20: Class 2 Device Recall Hospira
Figure 3 21: Class 2 Device Recall Hospira
Figure 3 22: Class 2 Device Recall Hospira
Figure 3 23: Class 2 Device Recall Smiths Medical
Figure 4 1: Currency Exchange Rate, 2017
Figure 4 2: Infusion Therapy Device Market By Segment, South Korea, 2014 – 2024 (Us$M)
Figure 4 3: Infusion Therapy Device Market By Segment, South Korea, 2014 – 2024 (Kr?M)
Figure 4 4: Infusion Therapy Device Market Growth By Segment, South Korea, 2014 – 2024
Figure 4 5: Drivers And Limiters, Infusion Therapy Device Market, South Korea, 2017
Figure 4 6: Leading Competitors, Infusion Therapy Device Market, South Korea, 2017
Figure 4 7: Swot Analysis, Baxter
Figure 4 8: Swot Analysis, B. Braun
Figure 4 9: Swot Analysis, Carefusion (Becton Dickinson)
Figure 4 10: Swot Analysis, Halyard
Figure 4 11: Swot Analysis, Hospira (Icu Medical)
Figure 4 12: Swot Analysis, Smiths Medical
Figure 5 1: Hospital Statistics, South Korea, 2014 – 2024
Figure 5 2: Infusion Pump Market By Segment, South Korea, 2014 – 2024 (Us$M)
Figure 5 3: Infusion Pump Market By Segment, South Korea, 2014 – 2024 (Kr?M)
Figure 5 4: Large Volume Infusion Pump Market, South Korea, 2014 – 2024
Figure 5 5: Syringe Infusion Pump Market By Segment, South Korea, 2014 – 2024 (Us$M)
Figure 5 6: Syringe Infusion Pump Market By Segment, South Korea, 2014 – 2024 (Kr?M)
Figure 5 7: Total Syringe Infusion Pump Market, South Korea, 2014 – 2024
Figure 5 8: Premium Syringe Pump Market, South Korea, 2014 – 2024
Figure 5 9: Value Brand Syringe Pump Market, South Korea, 2014 – 2024
Figure 5 10: Patient-Controlled Analgesia Infusion Pump Market, South Korea, 2014 – 2024
Figure 5 11: Electronic Ambulatory Infusion Pump Market, South Korea, 2014 – 2024
Figure 5 12: Disposable Ambulatory Infusion Pump Market By Segment, South Korea, 2014 – 2024 (Us$M)
Figure 5 13: Disposable Ambulatory Infusion Pump Market By Segment, South Korea, 2014 – 2024 (Kr?M)
Figure 5 14: Total Disposable Ambulatory Infusion Pump Market, South Korea, 2014 – 2024
Figure 5 15: Post-Operative Disposable Ambulatory Pump Market, South Korea, 2014 – 2024
Figure 5 16: Alternate Care Disposable Ambulatory Pump Market, South Korea, 2014 – 2024
Figure 5 17: Drivers And Limiters, Infusion Pump Market, South Korea, 2017
Figure 5 18: Leading Competitors, Infusion Pump Market, South Korea, 2017
Figure 6 1: Intravenous Set Market By Segment, South Korea, 2014 – 2024 (Us$M)
Figure 6 2: Intravenous Set Market By Segment, South Korea, 2014 – 2024 (Kr?M)
Figure 6 3: Dedicated Primary Iv Set Market, South Korea, 2014 – 2024
Figure 6 4: Secondary Iv Set Market, South Korea, 2014 – 2024
Figure 6 5: Iv Extension Set Market, South Korea, 2014 – 2024
Figure 6 6: Gravity Set Market, South Korea, 2014 – 2024
Figure 6 7: Drivers And Limiters, Intravenous Set Market, South Korea, 2017
Figure 6 8: Leading Competitors, Intravenous Set Market, South Korea, 2017
Figure 7 1: Needleless Connector Market Overview By Valve Type, South Korea, 2014 – 2024 (Us$M)
Figure 7 2: Needleless Connector Market Overview By Valve Type, South Korea, 2014 – 2024 (Kr?M)
Figure 7 3: Total Needleless Connector Market, South Korea, 2014 – 2024
Figure 7 4: Split Septum & Blunt Cannula Nlc Market, South Korea, 2014 – 2024
Figure 7 5: Mechanical Valve Nlc Market, South Korea, 2014 – 2024
Figure 7 6: Drivers And Limiters, Needleless Connector Market, South Korea, 2017
Figure 7 7: Leading Competitors, Needleless Connector Market, South Korea, 2017
Figure 8 1: Stopcock Market, South Korea, 2014 – 2024
Figure 8 2: Drivers And Limiters, Stopcock Market, South Korea, 2017
Figure 8 3: Market Competitors, Stopcock Market, South Korea, 2017
Figure 9 1: Blood Transfusion Set Market, South Korea, 2014 – 2024
Figure 9 2: Drivers And Limiters, Blood Transfusion Set Market, South Korea, 2017
Figure 9 3: Market Competitors, Blood Transfusion Set Market, South Korea, 2017
Figure 11 1: Press Release Summary
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Terumo
- Fresenius
- Ace Medical
- Woo Young
- Daiwha
- Arcomed
- Ewha
- B. Braun
- JMS
- AMPall
- Baxter